SYN News and Press, Synthetic Biologics Inc. From 02/27/19

ROCKVILLE, Md. , Feb. 27, 2019 /PRNewswire/ -- Synthetic Biologics, Inc.  (NYSE American: SYN), a clinical-stage company developing therapeutics that preserve the microbiome to protect and restore the health of patients, today provided a clinical programs update and report...

ROCKVILLE, Md. , Feb. 19, 2019 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a late-stage clinical company developing therapeutics designed to preserve the microbiome to protect and restore the health of patients, intends to report operational highlights and financial ...